Evaluation of Regional Pulmonary Ventilation in Spontaneously Breathing Patients with Idiopathic Pulmonary Fibrosis (IPF) Employing Electrical Impedance Tomography (EIT): A Pilot Study from the European IPF Registry (eurIPFreg)

Evaluation of Regional Pulmonary Ventilation in Spontaneously Breathing Patients with Idiopathic Pulmonary Fibrosis (IPF) Employing Electrical Impedance Tomography (EIT): A Pilot Study from the European IPF Registry (eurIPFreg)

Objectives: In idiopathic pulmonary fibrosis (IPF), alterations in the pulmonary surfactant system result in an increased alveolar surface tension and favor repetitive alveolar collapse. This study aimed to assess the usefulness of electrical impedance tomography (EIT) in characterization of regiona...

Full description

Bibliographic Details
Main Authors:	Ekaterina Krauss, Daniel van der Beck, Isabel Schmalz, Jochen Wilhelm, Silke Tello, Ruth C. Dartsch, Poornima Mahavadi, Martina Korfei, Eckhard Teschner, Werner Seeger, Andreas Guenther
Format:	Article
Language:	English
Published:	MDPI AG 2021-01-01
Series:	Journal of Clinical Medicine
Subjects:	idiopathic pulmonary fibrosis (IPF) electrical impedance tomography (EIT) European Registry for idiopathic pulmonary fibrosis (eurIPFreg) interstitial lung diseases (ILD)
Online Access:	https://www.mdpi.com/2077-0383/10/2/192

Similar Items

The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis
by: Andreas Guenther, et al.
Published: (2018-07-01)

Assessing the Effectiveness of Pirfenidone in Idiopathic Pulmonary Fibrosis: Long-Term, Real-World Data from European IPF Registry (eurIPFreg)
by: Ekaterina Krauss, et al.
Published: (2020-11-01)

Clinical and Functional Characteristics of Patients with Unclassifiable Interstitial Lung Disease (uILD): Long-Term Follow-Up Data from European IPF Registry (eurIPFreg)
by: Ekaterina Krauss, et al.
Published: (2020-08-01)

Clinical characteristics of patients with familial idiopathic pulmonary fibrosis (f-IPF)
by: Ekaterina Krauss, et al.
Published: (2019-07-01)

Factors associated with listing for lung transplantation in IPF patients: An analysis of the pulmonary fibrosis foundation registry
by: Christopher S. King, et al.
Published: (2023-08-01)

Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis
by: James Patrick Finnerty, et al.
Published: (2021-12-01)

Multiple complications of advanced IPF in an individual patient presentation
by: Thomas Ledger, et al.
Published: (2023-04-01)

Untargeted Metabolomics Reveals Alterations of Rhythmic Pulmonary Metabolism in IPF
by: Wei Sun, et al.
Published: (2023-10-01)

Design of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis
by: Tejaswini Kulkarni, et al.
Published: (2024-03-01)

Absence of early metabolic response assessed by 18F-FDG PET/CT after initiation of antifibrotic drugs in IPF patients
by: Benjamin Bondue, et al.
Published: (2019-01-01)

IPF patients are limited by mechanical and not pulmonary-vascular factors – results of a derivation-validation cohort study
by: Benjamin D. Fox, et al.
Published: (2019-12-01)

Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry
by: Helen E. Jo, et al.
Published: (2019-05-01)

Differential Transcriptomic Signatures of Small Airway Cell Cultures Derived from IPF and COVID-19-Induced Exacerbation of Interstitial Lung Disease
by: Katie Uhl, et al.
Published: (2023-10-01)

Senescent Cells in IPF: Locked in Repair?
by: Silke Meiners, et al.
Published: (2020-12-01)

Machine Learning and Single-Cell Analysis Identify Molecular Features of IPF-Associated Fibroblast Subtypes and Their Implications on IPF Prognosis
by: Jiwei Hou, et al.
Published: (2023-12-01)

Clinical Features, Diagnosis, Management, and Outcomes of Idiopathic Pulmonary Fibrosis in Korea: Analysis of the Korea IPF Cohort (KICO) Registry
by: Yangjin Jegal, et al.
Published: (2022-04-01)

Idiopathic pulmonary fibrosis: current diagnosis and treatment
by: Alexandre Franco Amaral, et al.
Published: (2023-08-01)

Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry
by: Helen E. Jo, et al.
Published: (2018-01-01)

Sex Differences in the Incidence and Outcomes of Patients Hospitalized by Idiopathic Pulmonary Fibrosis (IPF) in Spain from 2016 to 2019
by: Belén López-Muñiz Ballesteros, et al.
Published: (2021-08-01)

Severe Fatigue is Highly Prevalent in Patients with IPF or Sarcoidosis
by: Ada E. M. Bloem, et al.
Published: (2020-04-01)

Long-Term Safety of Antifibrotic Drugs in IPF: A Real-World Experience
by: Stefano Levra, et al.
Published: (2022-12-01)

Inhibition of LPA-LPAR1 and VEGF-VEGFR2 Signaling in IPF Treatment
by: Luo YL, et al.
Published: (2023-09-01)

Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry
by: Michael Kreuter, et al.
Published: (2017-07-01)

Exosomal circRNAs in the plasma serve as novel biomarkers for IPF diagnosis and progression prediction
by: Wenhua Gan, et al.
Published: (2024-03-01)

Mitochondrial Quality Control in COPD and IPF
by: Hiromichi Hara, et al.
Published: (2018-07-01)

Serum Progranulin Level Might Differentiate Non-IPF ILD from IPF
by: Nóra Melinda Tóth, et al.
Published: (2023-05-01)

Non-invasive continuous positive airway pressure in monolateral lung transplant patient with pneumonia and IPF
by: S. Aliberti, et al.
Published: (2016-01-01)

Systematic Review and Metanalysis of Oncomarkers in IPF Patients and Serial Changes of Oncomarkers in a Prospective Italian Real-Life Case Series
by: Miriana d’Alessandro, et al.
Published: (2021-01-01)

Baseline characteristics and survival of patients of idiopathic pulmonary fibrosis: a longitudinal analysis of the Swedish IPF Registry
by: Jing Gao, et al.
Published: (2021-02-01)

The Potential Effects of Curcumin on Pulmonary Fibroblasts of Idiopathic Pulmonary Fibrosis (IPF)—Approaching with Next-Generation Sequencing and Bioinformatics
by: Wei-An Chang, et al.
Published: (2020-11-01)

Lung immune signatures define two groups of end-stage IPF patients
by: Tamara Cruz, et al.
Published: (2023-09-01)

Management and attitudes about IPF (Idiopathic Pulmonary Fibrosis) among physicians from Latin America
by: Iván Cherrez-Ojeda, et al.
Published: (2018-01-01)

Editorial: Pulmonary fibrosis: One manifestation, various diseases
by: Barbara Ruaro, et al.
Published: (2022-10-01)

Clinical outcomes of dose modification during pirfenidone treatment for IPF: A nationwide post-marketing surveillance study
by: Jieun Kang, et al.
Published: (2023-01-01)

Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls
by: Kristina Krempaska, et al.
Published: (2020-01-01)

Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy
by: Miriana d’Alessandro, et al.
Published: (2021-02-01)

Historical eye on IPF: a cohort study redefining the mortality scenario
by: Sara Tomassetti, et al.
Published: (2023-06-01)

The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry
by: Michael Kreuter, et al.
Published: (2019-03-01)

Differential Genomic Profile in TERT, DSP, and FAM13A Between COPD Patients With Emphysema, IPF, and CPFE Syndrome
by: Javier Guzmán-Vargas, et al.
Published: (2021-08-01)

Effects of hypoxia and hyperoxia on the differential expression of VEGF-A isoforms and receptors in Idiopathic Pulmonary Fibrosis (IPF)
by: Shaney L. Barratt, et al.
Published: (2018-01-01)